Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2024-2032

Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A264
Buy Now

Market Overview:

The Indian diagnostic & therapeutic antibodies market size is projected to exhibit a growth rate (CAGR) of 6.11% during 2024-2032.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate 2024-2032 6.11%


Advancements in antibody technology has revolutionized both the diagnostic and therapeutic sciences. As of today, monoclonal antibodies can be produced virtually against any antigen and they have transformed the diagnostic industry in view of their specificity towards specific antigens and almost unlimited production capabilities. In the field of therapeutics, they have changed the treatment possibilities and significantly improved the life expectancies of patients who were earlier having very high unmet needs.

IMARC Group, one of the world’s leading research and advisory firms, in its latest report “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2024-2032” finds that the Indian market for both therapeutic and diagnostic antibodies is expected to grow exponentially in the coming years. Findings from the report suggest that more than 60% of the total antibodies market is currently dominated by diagnostic antibodies. This segment, however, is more mature, has lower entry barriers and is extremely price sensitive. The market for therapeutic antibodies in India, on the other hand, is still in its infancy and more than half of the globally launched therapeutic monoclonal antibodies are currently not even available here. In the coming years, however, we expect this market to explode. Driven by a continuous increase in healthcare expenditures, increasing affordability, and a number of new product launches, we expect the market for therapeutic antibodies to exhibit strong growth during 2024-2032.

IMARC’s new report entitled “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2024-2032” provides an analytical and statistical insight into the Indian Antibodies market. The study, that has been undertaken using desk-based as well as qualitative primary research, provides and draws upon analysis of the following aspects of the Indian antibodies market.

Key Aspects Analyzed:

Diagnostic Antibodies

Understanding the strengths, weaknesses, opportunities and challenges in the Indian diagnostic antibodies market

Understanding the technological considerations and regulatory factors in the Indian diagnostic antibodies market

  • Evaluating the various types of antibody based diagnostic tests conducted in India and analyzing their strengths and weaknesses
  • Understanding the key regulations for registering, manufacturing and importing diagnostics in India


Comprehensive situation analysis of the Indian diagnostic antibodies market
Segments covered: HIV, Hepatitis B, Hepatitis C, Tuberculosis, Dengue, Syphilis and Oncology


Focus of the analysis in each segment:

  • Number of tests conducted each year
  • Breakup by type of tests conducted
  • Current and future market sales
  • Average cost of diagnostic tests
  • Key players operating in the market


Therapeutic Antibodies

Understanding the strengths, weaknesses, opportunities and challenges in the Indian therapeutic antibodies market

Understanding the technological considerations and regulatory factors in the Indian therapeutic antibodies market

  • Evaluation and identification of monoclonal antibodies based on the sources from which they are derived and on the targets against which they act.
  • Understanding the key regulations for registering, manufacturing and importing therapeutic antibodies in India.


Evaluating the patent details of all globally marketed monoclonal antibodies in India, US and Europe

  • Identifying the patentee name and patent numbers of all in-market monoclonal antibodies in India, US and Europe
  • Identifying the monoclonal antibodies that are patent protected in India, US and Europe and those that are not
  • Estimating the patent expiries of various monoclonal antibodies in India, US and Europe.


Comprehensive situation analysis of the Indian therapeutic antibodies market

  • Analyzing current and future sales of monoclonal antibodies in India
  • Identifying all globally launched monoclonal antibodies and understanding their performance and launch status in India
  • Analyzing the global and Indian monoclonal antibodies market by Indication
  • Evaluation of the top selling monoclonal antibodies
  • Key biosimilar antibody development programmes in India and abroad

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More